We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App





Groundbreaking AI-Driven Sepsis Diagnosis Technology Could Guide Personalized Treatment for Hospitalized COVID-19 Patients

By HospiMedica International staff writers
Posted on 04 Feb 2022
Print article
Illustration
Illustration

A novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of unique molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen, could guide personalized treatment for hospitalized COVID-19 patients.

Asep Medical Holdings Inc. (Vancouver, BC, Canada) has finalized an exclusive licensing arrangement with the University of British Columbia (Vancouver, BC, Canada) for a patented and potentially groundbreaking AI-driven technology that enables early and accurate diagnosis of the deadly disease sepsis, which is also a major contributing factor in COVID-19 morbidity. Asep’s novel diagnostic test called SepsetER senses the dysfunctional immune response underlying sepsis at the time that patients first enter the emergency room. The test is a blood-based gene expression assay that is straightforward to implement, and results are obtained in about an hour in the emergency room or intensive care unit. Current diagnostic tools deliver results after approximately 24-36 hours often delaying the initiation of treatment. SepsetER is designed to enable physicians to quickly predict the severity of the disease and thus define better, more immediate treatment options for the patient.

Sepsis, a difficult-to-diagnose disease because of extensive variability in symptoms and outcomes, can be divided into five separate subtypes/endotypes according to the underlying biological mechanisms that drive the disease. Patients hospitalized with life-threatening COVID-19 also fit into these same endotypes, indicating that many COVID-19 patients have severe sepsis. Two endotypes are particularly associated with more severe sepsis and accompanying organ failure and patients falling into these two subtypes were more likely to die. The most severe form of sepsis, occurring in up to one-half of all hospitalized COVID-19 patients, can lead to multi-organ failure, the requirement for mechanical ventilation, and in many cases death.

Furthermore, many patients who recover from severe sepsis suffer from chronic medical issues which are very similar to those issues that afflict patients that suffer from long-term COVID-19 disease, termed long COVID. Being able to classify sepsis into the five sepsis endotypes could provide key information to physicians regarding the underlying mechanisms of disease and help guide personalized treatment options for those patients at greatest risk of severe sepsis. Asep's patent licensing arrangement with UBC gives it exclusive rights to develop the sepsis severity endotypes into a diagnostic test and bring the test to market.

"This technology will enable us to make a major impact on the lives of patients who acquire this deadly syndrome. Early and accurate diagnosis is vital to saving lives and we expect this technology to be widely used in hospitals and clinics around the world," said leading UBC microbiologist and the company's founding director and COO, Dr. Robert E.W. Hancock who led the development of the technology.

Related Links:
Asep Medical Holdings Inc.
The University of British Columbia 

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
Platinum Supplier
Respiratory Virus Multiplex Test
Respiratory Virus 12 Types Nucleic Acid Detection Kit
New
Silver Supplier
Whole Blood Quality Control
Meter Trax Control
New
Serratia Marcescens Test
CHROMagar Serratia

Print article
Radcal

Channels

AI

view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Critical Care

view channel
Image: PATHFAST is a compact immunoanalyzer with superior assay performance (Photo courtesy of PHC Europe)

Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC

A compact immunoanalyzer with superior assay performance combines the accuracy of a full-scale lab analyzer with the flexibility of a mobile solution, making it an ideal analysis system for laboratories,... Read more

Surgical Techniques

view channel
Image: Bioelectric medicine could stem excessive blood loss (Photo courtesy of Pexels)

Wearable Neurostimulation Solution Could Stem Excessive Blood Loss in the OR

A wearable neurostimulation solution focused on lessening excessive blood loss could save precious time for surgical teams in the operating room. A collaboration between Spark Biomedical, Inc.... Read more

Patient Care

view channel
Image: The digital stretcher scales are designed specifically for emergent situations in hospitals and emergency rooms (Photo courtesy of DETECTO)

Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER

For emergency arrivals into a hospital, time is of the essence for gathering patient weights. Now, digital stretcher scales specifically designed for emergent situations in hospitals and emergency rooms... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global visualization instruments for MIS market is estimated to surpass USD 21 billion by 2031 (Photo courtesy of Pexels)

Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures

The last few years have witnessed an increase in patient preference for medical surgeries that involve fewer incisions. As a result, the demand for visualization instruments, which aid in achieving improved... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.